F18.17 Inhalant abuse with inhalant-induced dementia

Name of the Condition

• Common Name: Inhalant Abuse with Inhalant-Induced Dementia
• Medical Term: Inhalant Abuse with Inhalant-Induced Dementia

Summary

Inhalant abuse with inhalant-induced dementia is a condition characterized by the intentional misuse of inhalants—substances that produce chemical vapors—to achieve psychoactive effects, accompanied by the development of dementia due to this abuse. This condition involves both substance-related impairment and cognitive decline, which can significantly impact an individual's daily functioning and overall health.

Causes

Inhalant abuse is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and, over time, contribute to the development of dementia through neurotoxic effects on the brain.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Difficulty with problem-solving or decision-making.
• Decline in social or occupational functioning.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other causes of cognitive impairment. Neuropsychological testing can help identify the extent of dementia, and imaging studies (e.g., MRI or CT scans) may reveal structural brain changes associated with inhalant-induced damage.

Treatment Options

Treatment focuses on addressing both the substance abuse and the dementia. This may include behavioral therapies to reduce inhalant use, cognitive rehabilitation to manage dementia symptoms, and supportive care to improve daily functioning. Medications may be used to manage withdrawal or co-occurring mental health conditions, though no specific treatments reverse inhalant-induced dementia.

Prognosis and Follow-Up

The prognosis depends on the severity of dementia and the individual's ability to maintain abstinence from inhalants. Early intervention may slow cognitive decline, but permanent damage is often irreversible. Regular follow-up is essential to monitor cognitive function, substance use, and overall health, with adjustments to treatment as needed.

Complications

• Irreversible cognitive decline or dementia.
• Worsening of mental health conditions (e.g., depression, anxiety).
• Increased risk of accidents or injuries due to impaired coordination.
• Social isolation or relationship difficulties.
• Financial or legal problems related to substance use.

Lifestyle & Prevention

• Avoiding inhalant use and removing access to these substances.
• Engaging in healthy activities to reduce stress or boredom.
• Seeking support from family, friends, or support groups.
• Educating oneself and others about the risks of inhalant abuse.
• Maintaining a structured daily routine to support cognitive function.

When to Seek Professional Help

Seek help if you or someone you know is using inhalants and experiencing cognitive decline, mood changes, or difficulty with daily tasks. Early intervention can improve outcomes. Contact a healthcare provider or mental health professional for evaluation and treatment.

Tips for Medical Coders

When coding for inhalant abuse with inhalant-induced dementia (F18.17), ensure documentation supports both the substance abuse and the dementia diagnosis. Include details on the type of inhalant use, duration, and evidence of cognitive impairment. Verify that the dementia is directly attributed to inhalant abuse, as opposed to other causes, to justify the code assignment.